Literature DB >> 26879360

How to Motivate Patients with Rheumatoid Arthritis to Quit Smoking.

Helen E Harris1, Fiona Tweedie2, Marie White2, Kay Samson2.   

Abstract

OBJECTIVE: Seropositive rheumatoid arthritis (RA) is strongly linked to cigarette smoking, and smoking cessation is an essential step in RA management. Our objectives were to develop RA and smoking awareness materials and to evaluate the influence of the materials on awareness about the links between RA and smoking and on motivation to quit smoking.
METHODS: A group of patients with seropositive RA in Fife, Scotland, were telephoned before the campaign, and the results of the precampaign questionnaire were used to develop the image for the campaign. After the campaign a second group of patients were questioned to ascertain the effect of the campaign.
RESULTS: The 320 patient responses to the precampaign questionnaire revealed that many ex-smokers with RA had quit when they developed a known smoking-related disease such as emphysema. This concept was used to develop an image illustrating that RA is a smoking-related disease. The campaign was launched in Fife in 2011. The postcampaign questionnaire involving 380 patients revealed that there was 21% higher awareness of a link between RA and smoking and 45% higher awareness that smoking could interfere with treatment of RA. In total, 13/75 smokers who had cut down since the campaign had been influenced by the new information.
CONCLUSION: The new materials have successfully increased patients' knowledge of the link between RA and smoking and the effect of smoking on RA therapy. RA smokers' attitudes to smoking may have been affected by the campaign.

Entities:  

Keywords:  CARDIOVASCULAR DISEASES; PSYCHOLOGY; RHEUMATOID ARTHRITIS; SMOKING

Mesh:

Year:  2016        PMID: 26879360     DOI: 10.3899/jrheum.141368

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Patient Perspectives on Smoking Cessation and Interventions in Rheumatology Clinics.

Authors:  Aimée Wattiaux; Brittany Bettendorf; Laura Block; Andrea Gilmore-Bykovskyi; Edmond Ramly; Megan E Piper; Ann Rosenthal; Jane Sadusky; Elizabeth Cox; Betty Chewning; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

2.  Impact of secondhand smoking on disease activity in women with rheumatoid arthritis.

Authors:  Nevin Hammam; Tamer A Gheita
Journal:  Clin Rheumatol       Date:  2017-08-25       Impact factor: 2.980

3.  The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Forough Azam Sayahpour; Bagher Larijani; Babak Arjmand
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.

Authors:  Ida K Roelsgaard; Bente A Esbensen; Mikkel Østergaard; Silvia Rollefstad; Anne G Semb; Robin Christensen; Thordis Thomsen
Journal:  Cochrane Database Syst Rev       Date:  2019-09-02

Review 5.  Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.

Authors:  James Bluett; Meghna Jani; Deborah P M Symmons
Journal:  Rheumatol Ther       Date:  2017-08-14

6.  Risks of smoking and benefits of smoking cessation on hospitalisations for cardiovascular events and respiratory infection in patients with rheumatoid arthritis: a retrospective cohort study using the Clinical Practice Research Datalink.

Authors:  Rebecca M Joseph; Mohammad Movahedi; William G Dixon; Deborah Pm Symmons
Journal:  RMD Open       Date:  2017-09-26

7.  How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study.

Authors:  Ida Kristiane Roelsgaard; Thordis Thomsen; Mikkel Østergaard; Anne Grete Semb; Lena Andersen; Bente Appel Esbensen
Journal:  Int J Qual Stud Health Well-being       Date:  2020-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.